TXG - 10x Genomics Inc - Ordinary Shares - Class A
IEX Last Trade
23.38
0.570 2.438%
Share volume: 2,348,207
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$22.81
0.57
2.50%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-03 | 2023-02-16 | 2023-05-04 | 2023-08-04 | 2023-11-03 | 2024-02-15 | 2024-04-30 | |
| Assets | |||||||||
| Total Assets | 1.002 B | 996.207 M | 1.029 B | 1.014 B | 989.638 M | 948.540 M | 965.143 M | 922.913 M | |
| Current Assets | 666.232 M | 629.422 M | 635.035 M | 601.894 M | 582.940 M | 562.348 M | 596.022 M | 567.093 M | |
| Inventories | 70.646 M | 78.629 M | 81.629 M | 82.307 M | 83.687 M | 80.917 M | 73.706 M | 83.189 M | |
| Other Current Assets | 19.141 M | 14.350 M | 16.578 M | 20.857 M | 18.683 M | 20.177 M | 18.789 M | 20.785 M | |
| Short Term Investments | 19.141 M | 14.350 M | 16.578 M | 20.857 M | 18.683 M | 20.177 M | 18.789 M | 20.785 M | |
| Total Receivables | 76.204 M | 83.549 M | 104.211 M | 77.940 M | 87.685 M | 103.847 M | 114.832 M | 91.305 M | |
| Current Cash | 499.733 M | 452.386 M | 429.984 M | 418.290 M | 391.385 M | 356.907 M | 388.695 M | 371.814 M | |
| Total Non-current Assets | 335.359 M | 366.785 M | 393.945 M | 412.136 M | 406.698 M | 386.192 M | 369.121 M | 355.820 M | |
| Property Plant Equipment | 223.001 M | 257.694 M | 289.328 M | 292.106 M | 284.913 M | 285.008 M | 279.571 M | 269.486 M | |
| Other Assets | 3.199 M | 2.901 M | 2.392 M | 12.859 M | 20.461 M | 2.674 M | 3.062 M | 2.844 M | |
| Intangible Assets | 24.128 M | 23.493 M | 22.858 M | 22.948 M | 22.290 M | 21.833 M | 16.616 M | 16.129 M | |
| Goodwill | 4.511 M | 4.511 M | 4.511 M | 4.511 M | 4.511 M | 4.511 M | 4.511 M | 4.511 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.002 B | 996.207 M | 1.029 B | 1.014 B | 989.638 M | 948.540 M | 965.143 M | 922.913 M | |
| Total liabilities | 218.075 M | 220.415 M | 223.237 M | 211.645 M | 196.337 M | 203.324 M | 224.100 M | 204.079 M | |
| Total current liabilities | 117.908 M | 126.855 M | 130.957 M | 112.006 M | 98.087 M | 104.717 M | 127.162 M | 108.733 M | |
| Accounts Payable | 26.731 M | 21.594 M | 21.599 M | 29.317 M | 23.124 M | 18.836 M | 15.738 M | 20.216 M | |
| Other liabilities | 9.127 M | 5.727 M | 6.141 M | 6.796 M | 7.919 M | 10.139 M | 13.089 M | 14.297 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 9.127 M | 5.727 M | 6.141 M | 6.796 M | 7.919 M | 10.139 M | 13.089 M | 14.297 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 783.516 M | 775.792 M | 805.743 M | 802.385 M | 793.301 M | 745.216 M | 741.043 M | 718.834 M | |
| Common stock | 113.575 M | 114.112 M | 114.781 M | 115.620 M | 116.708 M | 117.728 M | 118.604 M | 119.394 M | |
| Retained earnings | -970.192 M | -1.012 B | -1.029 B | -1.080 B | -1.142 B | -1.235 B | -1.284 B | -1.344 B |